A carregar...
Alternative treatments for melanoma: targeting BCL-2 family members to de-bulk and kill cancer stem cells
For the first time new treatments in melanoma have produced significant responses in advanced diseases, but 30–90% of melanoma patients do not respond or eventually relapse after the initial response to the current treatments. The resistance of these melanomas is likely due to tumor heterogeneity, w...
Na minha lista:
| Publicado no: | J Invest Dermatol |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4537369/ https://ncbi.nlm.nih.gov/pubmed/25947358 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/jid.2015.145 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|